VHP_web_banner_440_131On Tuesday 22 October a free BIA workshop – ‘Voluntary Harmonisation Procedure for multinational clinical trials in Europe and perspectives for the future‘ –  brought together senior experts from regulatory agencies and professionals from industry, contract research organisations, academic institutions/clinical trial units and medical research charities to share their experience of the Voluntary Harmonisation Procedure (VHP).

The VHP delivers significant benefits for the conduct of multinational clinical trials in Europe, and the event – which was kindly supported by Pfizer and hosted by law firm Taylor Wessing – was evidently timely given the interest from the life sciences community, as well as the important improvements to the VHP process which have been introduced by the Clinical Trials Facilitation Group (CTFG), a working group of the EU Heads of Medicines Agencies.

Read more about the day and view the presentations to discover the background of the VHP and hear views from clinical trials sponsors.